rs562740927

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 1P and 2B. PP5BP4BS1_Supporting

The NM_001386393.1(PANK2):​c.803A>G​(p.Asp268Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,614,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000043 ( 0 hom. )

Consequence

PANK2
NM_001386393.1 missense

Scores

5
5
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:2

Conservation

PhyloP100: 2.09
Variant links:
Genes affected
PANK2 (HGNC:15894): (pantothenate kinase 2) This gene encodes a protein belonging to the pantothenate kinase family and is the only member of that family to be expressed in mitochondria. Pantothenate kinase is a key regulatory enzyme in the biosynthesis of coenzyme A (CoA) in bacteria and mammalian cells. It catalyzes the first committed step in the universal biosynthetic pathway leading to CoA and is itself subject to regulation through feedback inhibition by acyl CoA species. Mutations in this gene are associated with HARP syndrome and pantothenate kinase-associated neurodegeneration (PKAN), formerly Hallervorden-Spatz syndrome. Alternative splicing, involving the use of alternate first exons, results in multiple transcripts encoding different isoforms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PP5
Variant 20-3910728-A-G is Pathogenic according to our data. Variant chr20-3910728-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 225428.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=2, Uncertain_significance=2, Pathogenic=1}.
BP4
Computational evidence support a benign effect (MetaRNN=0.08382577). . Strength limited to SUPPORTING due to the PP5.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.0000788 (12/152296) while in subpopulation EAS AF= 0.00212 (11/5192). AF 95% confidence interval is 0.00119. There are 0 homozygotes in gnomad4. There are 5 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PANK2NM_001386393.1 linkc.803A>G p.Asp268Gly missense_variant Exon 3 of 7 ENST00000610179.7 NP_001373322.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PANK2ENST00000610179.7 linkc.803A>G p.Asp268Gly missense_variant Exon 3 of 7 1 NM_001386393.1 ENSP00000477429.2 Q9BZ23-4

Frequencies

GnomAD3 genomes
AF:
0.0000789
AC:
12
AN:
152178
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00211
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000231
AC:
58
AN:
251334
Hom.:
0
AF XY:
0.000221
AC XY:
30
AN XY:
135830
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00310
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000431
AC:
63
AN:
1461862
Hom.:
0
Cov.:
32
AF XY:
0.0000495
AC XY:
36
AN XY:
727230
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00154
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152296
Hom.:
0
Cov.:
32
AF XY:
0.0000672
AC XY:
5
AN XY:
74460
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00212
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000577
Hom.:
0
Bravo
AF:
0.000125
ExAC
AF:
0.000264
AC:
32
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Pigmentary pallidal degeneration Pathogenic:3Uncertain:1
-
Juno Genomics, Hangzhou Juno Genomics, Inc
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

PM2_Supporting+PP3+PM3_Strong -

Mar 18, 2016
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: reference population

- -

Mar 14, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 378 of the PANK2 protein (p.Asp378Gly). This variant is present in population databases (rs562740927, gnomAD 0.3%). This missense change has been observed in individual(s) with pantothenate kinase-associated neurodegeneration (PMID: 15747360, 20193558, 26828213). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as p.Asp268Gly. ClinVar contains an entry for this variant (Variation ID: 225428). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PANK2 protein function. For these reasons, this variant has been classified as Pathogenic. -

Mar 24, 2024
Fulgent Genetics, Fulgent Genetics
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Uncertain:1
Jan 12, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: PANK2 c.1133A>G (p.Asp378Gly) results in a non-conservative amino acid change in the encoded protein sequence. Two of three in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00023 in 251536 control chromosomes, predominantly at a frequency of 0.0031 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 3 fold of the estimated maximal expected allele frequency for a pathogenic variant in PANK2 causing Pantothenate Kinase-Associated Neurodegeneration phenotype (0.0011), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. c.1133A>G has been reported in combination with another pathogenic variant in the literature in individuals affected with Pantothenate Kinase-Associated Neurodegeneration (Zhang_2005, Wu_2009, Mak_2011, Lim_2011, Kim_2012, Pan_2020, Yang_2022) and this variant is commonly affected alleles in Chinese origin (Zhang_2005, Wu_2009, Ma_2014, Ma_208, Pan_2020). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 35246191, 22547525, 24868354, 22103354, 24689511, 29801903, 21198414, 32310012, 20076801, 19224615, 15747360, 30681573). ClinVar contains an entry for this variant (Variation ID: 225428). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.043
T
BayesDel_noAF
Pathogenic
0.16
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.93
.;D;.;.
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.020
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.97
.;D;D;D
M_CAP
Pathogenic
0.31
D
MetaRNN
Benign
0.084
T;T;T;T
MetaSVM
Pathogenic
1.3
D
MutationAssessor
Benign
1.9
.;L;.;.
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-4.0
D;D;.;.
REVEL
Pathogenic
0.69
Sift
Benign
0.17
T;D;.;.
Sift4G
Benign
0.090
T;T;T;T
Polyphen
0.025
.;B;.;.
Vest4
0.54
MutPred
0.77
.;Loss of stability (P = 0.0131);.;.;
MVP
0.94
MPC
0.67
ClinPred
0.14
T
GERP RS
4.5
Varity_R
0.72
gMVP
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs562740927; hg19: chr20-3891375; API